ADVANCED BIOMARKER DETECTION
Aligned Bio’s patented nanowire waveguide platform technology improves sensitivity to targeted disease biomarkers by orders of magnitude over standard industry protocols. With this increased sensitivity, Aligned will be enabling the next generation of immunoassays for advanced point of care diagnostics, the use of significantly less fluids and multiplexing.
THE TECHNOLOGY BEHIND THE CAPABILITY
The underlying technology of these two application areas are nanowires of appropriate material and diameter to act like optical fibers that collect, guide and directionally emit light from fluorescent molecules bound to their surface.
This improved sensitivity has been demonstrated repeatably by our partners at Lund University’s Physics and Immunology departments, corporate partners and Chalmers University of Technology.